Invitae Expands Its Diagnostic Tests for Neuromuscular and Neurodegenerative Diseases

Invitae Corporation, a genetic diagnostics company for hereditary disorders, has expanded its available tests to include new panels for neurodegenerative and neuromuscular conditions. The diagnostic panels are updated as research reveals new genes of interest for various diseases, and the company has significantly expanded its neurology testing to include 17 genes associated with Parkinson’s disease, 78 genes covering neuropathies such as Charcot-Marie-Tooth (CMT) disease, and additional panels for hereditary spastic paraplegia and other motor neuropathies. To date, known ALS-associated genes, including SOD1, C9ORF72, and TDP-43 are not included.

Click here to read more.

disease-hereditary-neuropathies disease-pd topic-biomarkers topic-clinical topic-newmethods
Share this: